Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02909946 · ClinicalTrials.gov registry record · NA
Pathway From Functional Disability to Antimicrobial Resistance in Nursing Home Residents
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 246
- Enrollment target
NCT02909946 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 246 participants.
The verdict
NCT02909946, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 246 participants
- Enrollment target
Study Summary
Multidrug-resistant organisms (MDROs) are endemic in nursing homes (NHs) with prevalence rates surpassing those in hospitals. The aim of the study is to design and evaluate the effectiveness of a multi-component intervention to reduce new acquisition of MDROs in NH residents. The intervention will incorporate resident-level, environmental, and caregiver based strategies. Using a cluster-randomized study design, three NHs will be randomized to the intervention group and three to the control group. Control NHs will be allowed to continue standard infection prevention practices. Nursing homes will serve as the unit of allocation. Analyses will be performed both at the resident and the cluster level. The primary outcomes of the study are reduction in MDRO prevalence, and reduction in new MDRO acquisition .
Interventions
- BEHAVIORAL Multi-modal Infection Control Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2016-09-15 |
| Est. Completion | 2018-08-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02909946
The ClinicalTrials.gov registry entry for NCT02909946 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 246 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Multi-modal Infection Control Program is the first listed.
NCT02909946 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02909946 about?
NCT02909946 is a clinical study titled "Pathway From Functional Disability to Antimicrobial Resistance in Nursing Home Residents". Multidrug-resistant organisms (MDROs) are endemic in nursing homes (NHs) with prevalence rates surpassing those in hospitals. The aim of the study is to design and evaluate the effectiveness of a multi-component intervention to reduce new acquisition of MDROs in NH residents. The intervention will i...
What is the current status of trial NCT02909946?
This trial is currently completed. It is a NA study. The enrollment target is 246 participants. The study started on 2016-09-15. Estimated completion is 2018-08-29.
What interventions are being tested in trial NCT02909946?
The interventions under investigation include: Multi-modal Infection Control Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT02909946?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.